{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:42:21Z","timestamp":1794642141858,"version":"4.9.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019559","name":"Carl von Ossietzky Universit\u00e4t Oldenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019559","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Infections due to multidrug-resistant organisms (MDROs) are a health threat due to increasing patient morbidity and mortality and the burden on healthcare systems. Robust infection prevention and control (IPC) measures are needed to minimize their emergence in hospitals. Therefore, various international and national IPC guidelines exist, yet the lack of harmonized IPC guidelines complicates the management of patients seeking healthcare across European borders. This study explores the similarities and differences in IPC measures for vancomycin-resistant enterococci (VRE) and multidrug-resistant (MDR) <jats:italic>Enterobacterales<\/jats:italic> both on local and national levels within the northern Dutch-German cross-border region. In Germany, IPC efforts are often led by hospital hygiene doctors, whereas in the Netherlands, they involve a collaboration between infection preventionists and clinical microbiologists, with local variations. The local guidelines in both countries, as expected, are based on national recommendations, yet introduce specific regulations in various aspects. The Dutch guidelines are more stringent for VRE management compared to the German guidelines, often imposing additional local measures beyond national requirements. The Dutch and German guidelines largely diverge in definitions of MDR Gram-negative bacteria. Unlike the Dutch guidelines, the German guidelines do not currently recommend screening or isolation for extended-spectrum beta-lactamase-producing <jats:italic>Enterobacterales<\/jats:italic>. For carbapenem-resistant and carbapenemase-producing <jats:italic>Enterobacterales<\/jats:italic>, there is no notable distinction between the countries\u2019 guidelines, with both sharing the objective of maintaining a low prevalence and actively working towards containment. Inconsistencies in guidelines can lead to inefficient information exchange and inconsistent hygienic measures during patient transfers. Despite common commitments, differences in focus may reflect evolving understanding of MDRO transmission and ongoing debates on their management. Our findings highlight the divergence of IPC guidelines for the management of MDROs across two countries and call for collaboration in cross-border regions to increase the effectiveness of MDRO management in these regions and improve patient care.<\/jats:p>","DOI":"10.1186\/s13756-025-01528-3","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T11:53:06Z","timestamp":1739361186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Infection prevention and control without borders: comparison of guidelines on multidrug-resistant organisms in the northern Dutch-German cross-border region"],"prefix":"10.1186","volume":"14","author":[{"given":"Cansu","family":"Cimen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs S.","family":"Berends","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00ebtte","family":"Lokate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Glasner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Bathoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Hamprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"1528_CR1","doi-asserted-by":"publisher","unstructured":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022. Epub 2022\/01\/24. https:\/\/doi.org\/10.1016\/s0140-6736(21)02724-0. PubMed PMID: 35065702.","DOI":"10.1016\/s0140-6736(21)02724-0"},{"issue":"4","key":"1528_CR2","doi-asserted-by":"publisher","first-page":"E181","DOI":"10.1111\/1469-0691.12132","volume":"19","author":"AL Cheah","year":"2013","unstructured":"Cheah AL, Spelman T, Liew D, Peel T, Howden BP, Spelman D, et al. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization. Clin Microbiol Infect. 2013;19(4):E181\u20139. https:\/\/doi.org\/10.1111\/1469-0691.12132. Epub 2013\/02\/13.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"1528_CR3","doi-asserted-by":"publisher","first-page":"dlab068","DOI":"10.1093\/jacamr\/dlab068","volume":"3","author":"W Ling","year":"2021","unstructured":"Ling W, Furuya-Kanamori L, Ezure Y, Harris PNA, Paterson DL. Adverse clinical outcomes associated with infections by Enterobacterales producing ESBL (ESBL-E): a systematic review and meta-analysis. JAC Antimicrob Resist. 2021;3(2):dlab068. https:\/\/doi.org\/10.1093\/jacamr\/dlab068. Epub 20210602.","journal-title":"JAC Antimicrob Resist"},{"issue":"12","key":"1528_CR4","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1093\/cid\/ciad100","volume":"76","author":"M Falcone","year":"2023","unstructured":"Falcone M, Tiseo G, Carbonara S, Marino A, Di Caprio G, Carretta A, et al. Mortality attributable to Bloodstream infections caused by different carbapenem-resistant gram-negative Bacilli: results from a nationwide study in Italy (ALARICO Network). Clin Infect Dis. 2023;76(12):2059\u201369. https:\/\/doi.org\/10.1093\/cid\/ciad100. PubMed PMID: 36801828.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"1528_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1086\/501847","volume":"22","author":"M Eveillard","year":"2001","unstructured":"Eveillard M, Quenon JL, Rufat P, Mangeol A, Fauvelle F. Association between hospital-acquired infections and patients\u2019 transfers. Infect Control Hosp Epidemiol. 2001;22(11):693\u20136. https:\/\/doi.org\/10.1086\/501847. PubMed PMID: 11842989.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"1528_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/cid\/cir273","volume":"53","author":"BA Rogers","year":"2011","unstructured":"Rogers BA, Aminzadeh Z, Hayashi Y, Paterson DL. Country-to-country transfer of patients and the risk of multi-resistant bacterial infection. Clin Infect Dis. 2011;53(1):49\u201356. https:\/\/doi.org\/10.1093\/cid\/cir273. PubMed PMID: 21653302.","journal-title":"Clin Infect Dis"},{"issue":"6\u20137","key":"1528_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ijmm.2013.02.003","volume":"303","author":"M Ciccolini","year":"2013","unstructured":"Ciccolini M, Donker T, K\u00f6ck R, Mielke M, Hendrix R, Jurke A, et al. Infection prevention in a connected world: the case for a regional approach. Int J Med Microbiol. 2013;303(6\u20137):380\u20137. https:\/\/doi.org\/10.1016\/j.ijmm.2013.02.003. Epub 2013\/03\/19.","journal-title":"Int J Med Microbiol"},{"issue":"1","key":"1528_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s43999-023-00031-9","volume":"2","author":"L Schwettmann","year":"2023","unstructured":"Schwettmann L, Hamprecht A, Seeber GH, Pichler S, Voss A, Ansmann L, et al. Differences in healthcare structures, processes and outcomes of neighbouring European countries: the example of Germany and the Netherlands. Res Health Serv Reg. 2023;2(1):17. https:\/\/doi.org\/10.1007\/s43999-023-00031-9.","journal-title":"Res Health Serv Reg"},{"key":"1528_CR9","first-page":"1","volume":"14","author":"European Commission","year":"2015","unstructured":"European Commission. Eurobarometer results Programma Germany-Netherlands. Dec. 2015;14:1\u20135.","journal-title":"Dec"},{"key":"1528_CR10","unstructured":"The INTERREG. programme Deutschland\u2013 Nederland. https:\/\/interregv.deutschland-nederland.eu"},{"key":"1528_CR11","unstructured":"WHO Bacterial Priority Pathogens List. 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"1528_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-015-0047-6","author":"J M\u00fcller","year":"2015","unstructured":"M\u00fcller J, Voss A, K\u00f6ck R, Sinha B, Rossen JW, Kaase M, et al. Cross-border comparison of the Dutch and German guidelines on multidrug-resistant Gram-negative microorganisms. Antimicrob Resist Infect Control. 2015;4:7. https:\/\/doi.org\/10.1186\/s13756-015-0047-6. Epub 2015\/03\/13.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1528_CR13","doi-asserted-by":"publisher","unstructured":"Gunnink LB, Arouri DJ, Jolink FEJ, Lokate M, de Jonge K, Kampmeier S, et al. Compliance to Screening protocols for Multidrug-resistant microorganisms at the Emergency departments of two academic hospitals in the dutch-german Cross-border Region. Trop Med Infect Dis. 2021;6(1). https:\/\/doi.org\/10.3390\/tropicalmed6010015. PubMed PMID: 33530494; PubMed Central PMCID: PMCPMC7838951. Epub 2021\/02\/04.","DOI":"10.3390\/tropicalmed6010015"},{"key":"1528_CR14","doi-asserted-by":"publisher","unstructured":"Empfehlung der Kommission f\u00fcr Krankenhaushygiene und Infektionspr \u0308avention (KRINKO) beim Robert Koch Institut. Hygienema\u00dfnahmen Zur Pr\u00e4vention Der Infektion Durch Enterokokken Mit Speziellen Antibiotikaresistenzen. Bundesgesundheitsblt. 2018;611310\u201361. https:\/\/doi.org\/10.1007\/s00103-018-2811-2.","DOI":"10.1007\/s00103-018-2811-2"},{"key":"1528_CR15","doi-asserted-by":"publisher","unstructured":"Empfehlung der Kommission f\u00fcr Kranken-haushygiene. Infektionspr\u00e4vention (KRINKO) beim Robert Koch-Institut (RKI). Hygienema\u00dfnahmen Bei Infektionen oder Besiedlung Mit Multiresistenten Gramnegativen St\u00e4bchen. Bundesgesundheitsbl. 2012;551311\u201354. https:\/\/doi.org\/10.1007\/s00103-012-1549-5.","DOI":"10.1007\/s00103-012-1549-5"},{"key":"1528_CR16","unstructured":"Samenwerkingsverband Richtlijnen Infectiepreventie (SRI). Bijzonder resistente micro-organismen (BRMO) [October, 2024]. Available from: https:\/\/www.sri-richtlijnen.nl\/brmo"},{"key":"1528_CR17","doi-asserted-by":"publisher","unstructured":"Personelle. und organisatorische Voraussetzungen zur Pr\u00e4vention nosokomialer Infektionen Empfehlung der Kommission f\u00fcr Kranken- haushygiene und Infektionspr\u00e4vention (KRINKO) beim Robert Koch-Institut. Bundesgesundheitsbl 2023 \u00b7 66:332\u2013351. https:\/\/doi.org\/10.1007\/s00103-022-03647-3. Accesed 07 March 2024.","DOI":"10.1007\/s00103-022-03647-3"},{"issue":"2","key":"1528_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jhin.2006.10.003","volume":"65","author":"PJ van den Broek","year":"2007","unstructured":"van den Broek PJ, Kluytmans JA, Ummels LC, Voss A, Vandenbroucke-Grauls CM. How many infection control staff do we need in hospitals? J Hosp Infect. 2007;65(2):108\u201311. https:\/\/doi.org\/10.1016\/j.jhin.2006.10.003. Epub 2006\/12\/19.","journal-title":"J Hosp Infect"},{"key":"1528_CR19","unstructured":"Praktische Umsetzung sowie krankenhaushygienische und infektionspr\u00e4ventive Konsequenzen des mikrobiellen Kolonisationsscreenings bei intensivmedizinisch behandelten Fr\u00fch- und Neugeborenen. Mitteilung der Kommission f\u00fcr Krankenhaushygiene und Infektionspr\u00e4vention (KRINKO). [October, 2024]. Available from: https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2013\/Ausgaben\/42_13.pdf?__blob=publicationFile"},{"key":"1528_CR20","doi-asserted-by":"publisher","unstructured":"K\u00f6ck R, Becker K, Idelevich EA, Jurke A, Glasner C, Hendrix R et al. Prevention and Control of Multidrug-Resistant Bacteria in The Netherlands and Germany-The Impact of Healthcare Structures. Int J Environ Res Public Health. 2020;17(7). Epub 2020\/04\/03. https:\/\/doi.org\/10.3390\/ijerph17072337. PubMed PMID: 32235650; PubMed Central PMCID: PMCPMC7178045.","DOI":"10.3390\/ijerph17072337"},{"key":"1528_CR21","unstructured":"Cross-Border Institute of Healthcare Systems and Prevention. (CBI) [12.08.2024]. Available from: https:\/\/uol.de\/en\/cbi"},{"issue":"1","key":"1528_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jhin.2019.12.007","volume":"105","author":"C MacDougall","year":"2020","unstructured":"MacDougall C, Johnstone J, Prematunge C, Adomako K, Nadolny E, Truong E, et al. Economic evaluation of Vancomycin-resistant enterococci (VRE) control practices: a systematic review. J Hosp Infect. 2020;105(1):53\u201363. https:\/\/doi.org\/10.1016\/j.jhin.2019.12.007. Epub 20191217.","journal-title":"J Hosp Infect"},{"issue":"5","key":"1528_CR23","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1017\/ice.2021.189","volume":"43","author":"SY Cho","year":"2022","unstructured":"Cho SY, Kim HM, Chung DR, Choi JR, Lee MA, Huh HJ, et al. The impact of Vancomycin-resistant Enterococcus (VRE) screening policy change on the incidence of healthcare-associated VRE bacteremia. Infect Control Hosp Epidemiol. 2022;43(5):603\u20138. Epub 20210517. https:\/\/doi.org\/10.1017\/ice.2021.189. PubMed PMID: 33993892.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"1528_CR24","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1086\/655824","volume":"51","author":"S Tschudin Sutter","year":"2010","unstructured":"Tschudin Sutter S, Frei R, Dangel M, Gratwohl A, Bonten M, Widmer AF. Not all patients with Vancomycin-resistant enterococci need to be isolated. Clin Infect Dis. 2010;51(6):678\u201383. Epub 2010\/08\/07. https:\/\/doi.org\/10.1086\/655824. PubMed PMID: 20687839.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1528_CR25","doi-asserted-by":"publisher","first-page":"e221865","DOI":"10.1001\/jamanetworkopen.2022.1865","volume":"5","author":"J Kang","year":"2022","unstructured":"Kang J, Ji E, Kim J, Bae H, Cho E, Kim ES, et al. Evaluation of patients\u2019 adverse events during contact isolation for vancomycin-resistant Enterococci using a matched cohort study with propensity score. JAMA Netw Open. 2022;5(3):e221865. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.1865. Epub 20220301.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1528_CR26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13756-023-01278-0","volume":"12","author":"C Cimen","year":"2023","unstructured":"Cimen C, Berends MS, Bathoorn E, Lokate M, Voss A, Friedrich AW, et al. Vancomycin-resistant enterococci (VRE) in hospital settings across European borders: a scoping review comparing the epidemiology in the Netherlands and Germany. Antimicrob Resist Infect Control. 2023;12(1):78. https:\/\/doi.org\/10.1186\/s13756-023-01278-0. Epub 20230812.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1528_CR27","doi-asserted-by":"publisher","unstructured":"Glasner C, Berends MS, Becker K, Esser J, Gieffers J, Jurke A et al. A prospective multicentre screening study on multidrug-resistant organisms in intensive care units in the Dutch-German cross-border region, 2017 to 2018: the importance of healthcare structures. Euro Surveill. 2022;27(5). Epub 2022\/02\/05. https:\/\/doi.org\/10.2807\/1560-7917.Es.2022.27.5.2001660. PubMed PMID: 35115078.","DOI":"10.2807\/1560-7917.Es.2022.27.5.2001660"},{"issue":"6","key":"1528_CR28","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/s1473-3099","volume":"23","author":"RPJ Willems","year":"2023","unstructured":"Willems RPJ, van Dijk K, Vehreschild M, Biehl LM, Ket JCF, Remmelzwaal S, et al. Incidence of infection with multidrug-resistant Gram-negative bacteria and Vancomycin-resistant enterococci in carriers: a systematic review and meta-regression analysis. Lancet Infect Dis. 2023;23(6):719\u201331. https:\/\/doi.org\/10.1016\/s1473-3099. Epub 20230130.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1528_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13756-022-01051-9","volume":"11","author":"D Vuichard-Gysin","year":"2022","unstructured":"Vuichard-Gysin D, Sommerstein R, Kronenberg A, Buetti N, Eder M, Piezzi V, et al. High adherence to national IPC guidelines as key to sustainable VRE control in Swiss hospitals: a cross-sectional survey. Antimicrob Resist Infect Control. 2022;11(1):19. https:\/\/doi.org\/10.1186\/s13756-022-01051-9. Epub 2022\/01\/30.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"43","key":"1528_CR30","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3238\/arztebl.2013.0725","volume":"110","author":"NT Mutters","year":"2013","unstructured":"Mutters NT, Mersch-Sundermann V, Mutters R, Brandt C, Schneider-Brachert W, Frank U. Control of the spread of Vancomycin-resistant enterococci in hospitals: epidemiology and clinical relevance. Dtsch Arztebl Int. 2013;110(43):725\u201331. https:\/\/doi.org\/10.3238\/arztebl.2013.0725. Epub 2013\/11\/14.","journal-title":"Dtsch Arztebl Int"},{"issue":"15","key":"1528_CR31","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/NEJMoa1000373","volume":"364","author":"WC Huskins","year":"2011","unstructured":"Huskins WC, Huckabee CM, O\u2019Grady NP, Murray P, Kopetskie H, Zimmer L, et al. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med. 2011;364(15):1407\u201318. https:\/\/doi.org\/10.1056\/NEJMoa1000373. Epub 2011\/04\/15.","journal-title":"N Engl J Med"},{"issue":"9","key":"1528_CR32","doi-asserted-by":"publisher","first-page":"e0222200","DOI":"10.1371\/journal.pone.0222200","volume":"14","author":"E van Dulm","year":"2019","unstructured":"van Dulm E, Tholen ATR, Pettersson A, van Rooijen MS, Willemsen I, Molenaar P, et al. High prevalence of multidrug resistant Enterobacteriaceae among residents of long term care facilities in Amsterdam, the Netherlands. PLoS ONE. 2019;14(9):e0222200. https:\/\/doi.org\/10.1371\/journal.pone.0222200. Epub 20190912.","journal-title":"PLoS ONE"},{"issue":"6","key":"1528_CR33","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1093\/jac\/dku035","volume":"69","author":"P Gastmeier","year":"2014","unstructured":"Gastmeier P, Schr\u00f6der C, Behnke M, Meyer E, Geffers C. Dramatic increase in Vancomycin-resistant enterococci in Germany. J Antimicrob Chemother. 2014;69(6):1660\u20134. https:\/\/doi.org\/10.1093\/jac\/dku035. Epub 2014\/03\/13.","journal-title":"J Antimicrob Chemother"},{"key":"1528_CR34","doi-asserted-by":"publisher","unstructured":"Sommer L, Hackel T, Hofmann A, Hoffmann J, Hennebach E, K\u00f6pke B et al. [Multi-Resistant Bacteria in Patients in Hospitals and Medical Practices as well as in Residents of Nursing Homes in Saxony - Results of a Prevalence Study 2017\/2018]. Gesundheitswesen. 2020. Epub 2020\/05\/08. https:\/\/doi.org\/10.1055\/a-1138-0489. PubMed PMID: 32380560.","DOI":"10.1055\/a-1138-0489"},{"key":"1528_CR35","doi-asserted-by":"publisher","unstructured":"Zhou X, Garc\u00eda-Cobos S, Ruijs G, Kampinga GA, Arends JP, Borst DM, et al. Epidemiology of Extended-Spectrum \u03b2-Lactamase-Producing E. coli and Vancomycin-Resistant Enterococci in the Northern Dutch-German Cross-Border Region. Front Microbiol. 2017. https:\/\/doi.org\/10.3389\/fmicb.2017.01914. Epub 2017\/10\/21. 8:1914.","DOI":"10.3389\/fmicb.2017.01914"},{"issue":"12","key":"1528_CR36","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1086\/647041","volume":"16","author":"MA Montecalvo","year":"1995","unstructured":"Montecalvo MA, de Lencastre H, Carraher M, Gedris C, Chung M, VanHorn K, et al. Natural history of colonization with Vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol. 1995;16(12):680\u20135. https:\/\/doi.org\/10.1086\/647041. PubMed PMID: 8683085.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1528_CR37","doi-asserted-by":"publisher","unstructured":"Kim AS. Using the good to beat out the bad: probiotics for eliminating vancomycin-resistant enterococci colonization. J Clin Gastroenterol. 2011;45(10):844-5. https:\/\/doi.org\/10.1097\/MCG.0b013e31823336cd. PubMed PMID: 21989278.","DOI":"10.1097\/MCG.0b013e31823336cd"},{"issue":"10","key":"1528_CR38","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1086\/323762","volume":"33","author":"LR Baden","year":"2001","unstructured":"Baden LR, Thiemke W, Skolnik A, Chambers R, Strymish J, Gold HS, et al. Prolonged colonization with Vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of clearance. Clin Infect Dis. 2001;33(10):1654\u201360. Epub 20011010. https:\/\/doi.org\/10.1086\/323762. PubMed PMID: 11595985.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1528_CR39","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jhin.2014.09.011","volume":"88","author":"A Ghosh","year":"2014","unstructured":"Ghosh A, Jiao L, Al-Mutawa F, O\u2019Neill C, Mertz D. Value of an active surveillance policy to document clearance of meticillin-resistant Staphylococcus aureus and Vancomycin-resistant enterococci amongst inpatients with prolonged admissions. J Hosp Infect. 2014;88(4):230\u20133. https:\/\/doi.org\/10.1016\/j.jhin.2014.09.011. Epub 20141018.","journal-title":"J Hosp Infect"},{"issue":"22","key":"1528_CR40","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1002\/pmic.201500138","volume":"15","author":"JC Sinnige","year":"2015","unstructured":"Sinnige JC, de Been M, Zhou M, Bonten MJ, Willems RJ, Top J. Growth condition-dependent cell surface proteome analysis of Enterococcus faecium. Proteomics. 2015;15(22):3806\u201314. https:\/\/doi.org\/10.1002\/pmic.201500138. Epub 20151002.","journal-title":"Proteomics"},{"issue":"7","key":"1528_CR41","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1128\/jcm.00258-17","volume":"55","author":"JM Fonville","year":"2017","unstructured":"Fonville JM, van Herk CMC, Das P, van de Bovenkamp JHB, van Dommelen L. A single negative result for Van quantitative PCR on Enrichment Broth can replace five rectal swab cultures in screening for vancomycin-resistant Enterococci. J Clin Microbiol. 2017;55(7):2261\u20137. https:\/\/doi.org\/10.1128\/jcm.00258-17. Epub 20170510.","journal-title":"J Clin Microbiol"},{"key":"1528_CR42","doi-asserted-by":"publisher","unstructured":"K\u00f6ck R, Siemer P, Esser J, Kampmeier S, Berends MS, Glasner C et al. Defining Multidrug Resistance of Gram-Negative Bacteria in the Dutch-German Border Region-Impact of National Guidelines. Microorganisms. 2018;6(1). Epub 20180126. https:\/\/doi.org\/10.3390\/microorganisms6010011. PubMed PMID: 29373498; PubMed Central PMCID: PMCPMC5874625.","DOI":"10.3390\/microorganisms6010011"},{"issue":"3","key":"1528_CR43","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/s1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318\u201327. https:\/\/doi.org\/10.1016\/s1473-3099(17)30753-3. Epub 2017\/12\/26.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"1528_CR44","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jhin.2020.09.006","volume":"106","author":"J Vink","year":"2020","unstructured":"Vink J, Edgeworth J, Bailey SL. Acquisition of MDR-GNB in hospital settings: a systematic review and meta-analysis focusing on ESBL-E. J Hosp Infect. 2020;106(3):419\u201328. https:\/\/doi.org\/10.1016\/j.jhin.2020.09.006. Epub 20200909.","journal-title":"J Hosp Infect"},{"issue":"12","key":"1528_CR45","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.cmi.2015.09.021","volume":"21","author":"JA Otter","year":"2015","unstructured":"Otter JA, Mutters NT, Tacconelli E, Gikas A, Holmes AH. Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries. Clin Microbiol Infect. 2015;21(12):1057\u201366. https:\/\/doi.org\/10.1016\/j.cmi.2015.09.021. Epub 20151003.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"1528_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/1040841x.2013.875515","volume":"42","author":"LM Biehl","year":"2016","unstructured":"Biehl LM, Schmidt-Hieber M, Liss B, Cornely OA, Vehreschild MJ. Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients - review of the literature from a clinical perspective. Crit Rev Microbiol. 2016;42(1):1\u201316. https:\/\/doi.org\/10.3109\/1040841x.2013.875515. Epub 20140204.","journal-title":"Crit Rev Microbiol"},{"issue":"8","key":"1528_CR47","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.cmi.2019.11.025","volume":"26","author":"LA Denkel","year":"2020","unstructured":"Denkel LA, Maechler F, Schwab F, Kola A, Weber A, Gastmeier P, et al. Infections caused by extended-spectrum \u03b2-lactamase-producing enterobacterales after rectal colonization with ESBL-producing Escherichia coli or Klebsiella pneumoniae. Clin Microbiol Infect. 2020;26(8):1046\u201351. PubMed PMID: 31809805.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"1528_CR48","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cmi.2014.09.014","volume":"21","author":"TN Platteel","year":"2015","unstructured":"Platteel TN, Leverstein-van Hall MA, Cohen Stuart JW, Thijsen SF, Mascini EM, van Hees BC, et al. Predicting carriage with extended-spectrum beta-lactamase-producing bacteria at hospital admission: a cross-sectional study. Clin Microbiol Infect. 2015;21(2):141\u20136. https:\/\/doi.org\/10.1016\/j.cmi.2014.09.014. Epub 20141029.","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"1528_CR49","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1086\/345921","volume":"186","author":"MA Gardam","year":"2002","unstructured":"Gardam MA, Burrows LL, Kus JV, Brunton J, Low DE, Conly JM, et al. Is surveillance for multidrug-resistant enterobacteriaceae an effective infection control strategy in the absence of an outbreak? J Infect Dis. 2002;186(12):1754\u201360. Epub 20021114. https:\/\/doi.org\/10.1086\/345921. PubMed PMID: 12447761.","journal-title":"J Infect Dis"},{"issue":"10","key":"1528_CR50","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1086\/502305","volume":"25","author":"M Thouverez","year":"2004","unstructured":"Thouverez M, Talon D, Bertrand X. Control of Enterobacteriaceae producing extended-spectrum beta-lactamase in intensive care units: rectal screening may not be needed in non-epidemic situations. Infect Control Hosp Epidemiol. 2004;25(10):838\u201341. https:\/\/doi.org\/10.1086\/502305. PubMed PMID: 15518025.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"1528_CR51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jhin.2007.01.006","volume":"66","author":"A Kola","year":"2007","unstructured":"Kola A, Holst M, Chaberny IF, Ziesing S, Suerbaum S, Gastmeier P. Surveillance of extended-spectrum beta-lactamase-producing bacteria and routine use of contact isolation: experience from a three-year period. J Hosp Infect. 2007;66(1):46\u201351. https:\/\/doi.org\/10.1016\/j.jhin.2007.01.006. Epub 20070312.","journal-title":"J Hosp Infect"},{"issue":"6","key":"1528_CR52","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/jac\/dkaa052","volume":"75","author":"AM Rohde","year":"2020","unstructured":"Rohde AM, Zweigner J, Wiese-Posselt M, Schwab F, Behnke M, Kola A, et al. Prevalence of third-generation cephalosporin-resistant Enterobacterales colonization on hospital admission and ESBL genotype-specific risk factors: a cross-sectional study in six German university hospitals. J Antimicrob Chemother. 2020;75(6):1631\u20138. https:\/\/doi.org\/10.1093\/jac\/dkaa052. Epub 2020\/03\/17.","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"1528_CR53","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1093\/jac\/dkw216","volume":"71","author":"A Hamprecht","year":"2016","unstructured":"Hamprecht A, Rohde AM, Behnke M, Feihl S, Gastmeier P, Gebhardt F, et al. Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors. J Antimicrob Chemother. 2016;71(10):2957\u201363. https:\/\/doi.org\/10.1093\/jac\/dkw216. Epub 2016\/06\/19.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"1528_CR54","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1017\/s0950268811000781","volume":"140","author":"A Kohlenberg","year":"2012","unstructured":"Kohlenberg A, Schwab F, R\u00fcden H. Wide dissemination of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in acute care and rehabilitation hospitals. Epidemiol Infect. 2012;140(3):528\u201334. https:\/\/doi.org\/10.1017\/s0950268811000781. Epub 20110517.","journal-title":"Epidemiol Infect"},{"issue":"5\u20136","key":"1528_CR55","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s15010-005-5045-9","volume":"33","author":"C Wendt","year":"2005","unstructured":"Wendt C, Lin D, von Baum H. Risk factors for colonization with third-generation cephalosporin-resistant enterobacteriaceae. Infection. 2005;33(5\u20136):327\u201332. https:\/\/doi.org\/10.1007\/s15010-005-5045-9. PubMed PMID: 16258862.","journal-title":"Infection"},{"issue":"1","key":"1528_CR56","doi-asserted-by":"publisher","first-page":"e0208505","DOI":"10.1371\/journal.pone.0208505","volume":"14","author":"S Hagel","year":"2019","unstructured":"Hagel S, Makarewicz O, Hartung A, Wei\u00df D, Stein C, Brandt C, et al. ESBL colonization and acquisition in a hospital population: the molecular epidemiology and transmission of resistance genes. PLoS ONE. 2019;14(1):e0208505. https:\/\/doi.org\/10.1371\/journal.pone.0208505. Epub 20190114.","journal-title":"PLoS ONE"},{"issue":"12","key":"1528_CR57","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1093\/jac\/dku305","volume":"69","author":"MJ Vehreschild","year":"2014","unstructured":"Vehreschild MJ, Hamprecht A, Peterson L, Schubert S, H\u00e4ntschel M, Peter S, et al. A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies. J Antimicrob Chemother. 2014;69(12):3387\u201392. https:\/\/doi.org\/10.1093\/jac\/dku305. Epub 20140806.","journal-title":"J Antimicrob Chemother"},{"key":"1528_CR58","doi-asserted-by":"publisher","unstructured":"Voor In \u2018t Holt AF, van der Schoor AS, Mourik K, Strepis N, Klaassen CHW, Vos MC, et al. Pre-COVID-19 international travel and admission to hospital when back home: travel behavior, carriage of highly resistant microorganisms, and risk perception of patients admitted to a large tertiary care hospital. Antimicrob Resist Infect Control. 2022;11(1):78. Epub 20220602. https:\/\/doi.org\/10.1186\/s13756-022-01106-x. PubMed PMID: 35655236; PubMed Central PMCID: PMCPMC9161189.","DOI":"10.1186\/s13756-022-01106-x"},{"key":"1528_CR59","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jhin.2020.12.007","volume":"109","author":"D van Hout","year":"2021","unstructured":"van Hout D, Bruijning-Verhagen PCJ, Blok HEM, Troelstra A, Bonten MJM. Universal risk assessment upon hospital admission for screening of carriage with multidrug-resistant micro-organisms in a Dutch tertiary care centre. J Hosp Infect. 2021;109:32\u20139. https:\/\/doi.org\/10.1016\/j.jhin.2020.12.007. Epub 20201224.","journal-title":"J Hosp Infect"},{"key":"1528_CR60","doi-asserted-by":"publisher","unstructured":"Kajova M, Khawaja T, Kangas J, M\u00e4kinen H, Kantele A. Import of multidrug-resistant bacteria from abroad through interhospital transfers, Finland, 2010\u20132019. Euro Surveill. 2021;26(39). https:\/\/doi.org\/10.2807\/1560-7917.Es.2021.26.39.2001360. PubMed PMID: 34596014; PubMed Central PMCID: PMCPMC8485579.","DOI":"10.2807\/1560-7917.Es.2021.26.39.2001360"},{"key":"1528_CR61","doi-asserted-by":"publisher","unstructured":"Aro T, Kantele A. High rates of meticillin-resistant Staphylococcus aureus among asylum seekers and refugees admitted to Helsinki University Hospital, 2010 to 2017. Euro Surveill. 2018;23(45). https:\/\/doi.org\/10.2807\/1560-7917.Es.2018.23.45.1700797. PubMed PMID: 30424828; PubMed Central PMCID: PMCPMC6234530.","DOI":"10.2807\/1560-7917.Es.2018.23.45.1700797"},{"key":"1528_CR62","doi-asserted-by":"publisher","unstructured":"Ehlkes L, Pfeifer Y, Werner G, Ignatius R, Vogt M, Eckmanns T et al. No evidence of carbapenemase-producing Enterobacteriaceae in stool samples of 1,544 asylum seekers arriving in Rhineland-Palatinate, Germany, April 2016 to March, 2017. Euro Surveill. 2019;24(8). https:\/\/doi.org\/10.2807\/1560-7917.Es.2019.24.8.1800030. PubMed PMID: 30808444; PubMed Central PMCID: PMCPMC6446954.","DOI":"10.2807\/1560-7917.Es.2019.24.8.1800030"},{"issue":"10","key":"1528_CR63","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/s1473-3099(19)30262-2","volume":"19","author":"MFQ Kluytmans-van den Bergh","year":"2019","unstructured":"Kluytmans-van den Bergh MFQ, Bruijning-Verhagen PCJ, Vandenbroucke-Grauls C, de Brauwer E, Buiting AGM, Diederen BM, et al. Contact precautions in single-bed or multiple-bed rooms for patients with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in Dutch hospitals: a cluster-randomised, crossover, non-inferiority study. Lancet Infect Dis. 2019;19(10):1069\u201379. https:\/\/doi.org\/10.1016\/s1473-3099(19)30262-2. Epub 20190823.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1528_CR64","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/2047-2994-3-5","volume":"3","author":"JT Freeman","year":"2014","unstructured":"Freeman JT, Nimmo J, Gregory E, Tiong A, De Almeida M, McAuliffe GN, et al. Predictors of hospital surface contamination with extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae: patient and organism factors. Antimicrob Resist Infect Control. 2014;3(1):5. https:\/\/doi.org\/10.1186\/2047-2994-3-5. Epub 20140204.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"11","key":"1528_CR65","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/cid\/cis770","volume":"55","author":"S Tschudin-Sutter","year":"2012","unstructured":"Tschudin-Sutter S, Frei R, Dangel M, Stranden A, Widmer AF. Rate of transmission of extended-spectrum beta-lactamase-producing enterobacteriaceae without contact isolation. Clin Infect Dis. 2012;55(11):1505\u201311. https:\/\/doi.org\/10.1093\/cid\/cis770. Epub 20120905.","journal-title":"Clin Infect Dis"},{"key":"1528_CR66","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13756-019-0614-3","volume":"8","author":"A Wolfensberger","year":"2019","unstructured":"Wolfensberger A, Kuster SP, Marchesi M, Zbinden R, Hombach M. The effect of varying multidrug-resistence (MDR) definitions on rates of MDR gram-negative rods. Antimicrob Resist Infect Control. 2019;8:193. https:\/\/doi.org\/10.1186\/s13756-019-0614-3. Epub 20191128.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1528_CR67","volume-title":"Antimicrobial resistance in the EU\/EEA (EARS-Net) - Annual Epidemiological Report 2021","author":"European Centre for Disease Prevention and Control","year":"2022","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU\/EEA (EARS-Net) - Annual Epidemiological Report 2021. Stockholm: ECDC; 2022."},{"key":"1528_CR68","volume-title":"Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE) through patient transfer between healthcare facilities, with special emphasis on cross-border transfer","author":"European Centre for Disease Prevention and Control","year":"2011","unstructured":"European Centre for Disease Prevention and Control. Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE) through patient transfer between healthcare facilities, with special emphasis on cross-border transfer. Stockholm: ECDC; 2011."},{"key":"1528_CR69","volume-title":"Systematic review of the effectiveness of infection control measures to prevent the transmission of extended-spectrum beta-lactamase- producing Enterobacteriaceae through cross-border transfer of patients","author":"European Centre for Disease Prevention and Control","year":"2014","unstructured":"European Centre for Disease Prevention and Control. Systematic review of the effectiveness of infection control measures to prevent the transmission of extended-spectrum beta-lactamase- producing Enterobacteriaceae through cross-border transfer of patients. Stockholm: ECDC; 2014."},{"key":"1528_CR70","doi-asserted-by":"publisher","unstructured":"Friedrich AW, Daniels-Haardt I, K\u00f6ck R, Verhoeven F, Mellmann A, Harmsen D et al. EUREGIO MRSA-net Twente\/M\u00fcnsterland\u2013a Dutch-German cross-border network for the prevention and control of infections caused by methicillin-resistant Staphylococcus aureus. Euro Surveill. 2008;13(35). Epub 2008\/09\/03. https:\/\/doi.org\/10.2807\/ese.13.35.18965-en. PubMed PMID: 18761882.","DOI":"10.2807\/ese.13.35.18965-en"},{"key":"1528_CR71","doi-asserted-by":"publisher","unstructured":"Jurke A, Daniels-Haardt I, Silvis W, Berends MS, Glasner C, Becker K et al. Changing epidemiology of meticillin-resistant Staphylococcus aureus in 42 hospitals in the dutch-german border region, 2012 to 2016: results of the search-and-follow-policy. Euro Surveill. 2019;24(15). Epub 2019\/04\/18. https:\/\/doi.org\/10.2807\/1560-7917.Es.2019.24.15.1800244. PubMed PMID: 30994105; PubMed Central PMCID: PMCPMC6470371.","DOI":"10.2807\/1560-7917.Es.2019.24.15.1800244"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-025-01528-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-025-01528-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-025-01528-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T11:53:13Z","timestamp":1739361193000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01528-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1528"],"URL":"https:\/\/doi.org\/10.1186\/s13756-025-01528-3","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"assertion":[{"value":"2 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}